Founders, clinicians, researchers, investors and journalists are defining what comes next. OVUM brings their original perspectives into view, with the source, the industry context and the evidence beside them.
Investor on health equity as investable thesis.
“Women's health equity is not charity — it's the largest underserved market in healthcare.”Read original post
Reframes equity as TAM, not ESG. This is how the thesis will be sold to LPs in the next fund cycle.
Industry conversations begin with people. OVUM connects attributed posts and reported perspectives to funding, company activity, research and policy so readers can see what is changing, where the evidence is and who is leading the conversation.
The diagnostics, therapeutics, clinics, and data forming around hormonal health across the female lifespan — from adolescence to menopause.
Physician on the policy gap for menopause care.
Original sourceReframing menopause care around equity of experience.
Original sourceUrologist on women's health as mainstream medicine.
Original sourceOperator on menopause care access and payer coverage.
Original sourcePhysician calling out menopause-washing in consumer brands.
Original sourceAt-home diagnostics, vertically integrated clinics, employer benefits, and the capital reshaping how people build families.
RESOLVE CEO on institutional advocacy.
Original sourceResearch surfacing new ovarian aging pathways.
Original sourceThe on-ramp to the rest of the stack — at-home, in-clinic, and longitudinal diagnostics rewiring how women enter the system.
Data visualization of the women's health research deficit.
Original sourceIndustry take on stratified diagnostics for women's health.
Original sourceFemale aging biology, biomarkers, and the clinics, research centers, and capital rebuilding longevity around female physiology.
Operator mapping peptide use cases in women's health.
Original sourceCapital allocators moving into longevity health-tech.
Original sourceLongevity biotech extending into women's health biology.
Original sourceConsumer take on the peptide clinic experience.
Original sourceClinics, employer benefits, data layers, and operator infrastructure connecting the women's health stack end-to-end.
Operator preview of institutional women's health convenings.
Original sourceOperator on AI applied to caregiving workflows.
Original sourceCommunity call surfacing under-funded pelvic health founders.
Original sourcePE / private capital moves into women's health platforms.
Original sourceDTC brands, period care, sexual wellness, supplements, skin, and the consumer products being built around women's health stages.
LP-facing thesis for femtech portfolio construction.
Original sourceAggregate VC take on current deal environment.
Original sourcePhilanthropic capital re-entering women's health at scale.
Original sourceConsumer operator on standout product launches.
Original sourceConsumer operator on category convergence.
Original sourceFounder reframing femtech under a broader consumer health lens.
Original sourceMarketing lead on the power (and risk) of category labels.
Original sourceInvestor commentary on the sharp decline in women's health venture funding.
Original sourceJournalist critique of platform algorithms suppressing women's health content.
Original source